328 related articles for article (PubMed ID: 28442547)
1. Biosynthesis of proresolving lipid mediators by vascular cells and tissues.
Chatterjee A; Komshian S; Sansbury BE; Wu B; Mottola G; Chen M; Spite M; Conte MS
FASEB J; 2017 Aug; 31(8):3393-3402. PubMed ID: 28442547
[TBL] [Abstract][Full Text] [Related]
2. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.
Chiurchiù V; Leuti A; Dalli J; Jacobsson A; Battistini L; Maccarrone M; Serhan CN
Sci Transl Med; 2016 Aug; 8(353):353ra111. PubMed ID: 27559094
[TBL] [Abstract][Full Text] [Related]
3. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1.
Shi H; Carion TW; Jiang Y; Steinle JJ; Berger EA
Prostaglandins Other Lipid Mediat; 2016 Mar; 123():28-32. PubMed ID: 27026343
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.
Krishnamoorthy S; Recchiuti A; Chiang N; Fredman G; Serhan CN
Am J Pathol; 2012 May; 180(5):2018-27. PubMed ID: 22449948
[TBL] [Abstract][Full Text] [Related]
6. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
Lee HJ; Park MK; Lee EJ; Lee CH
Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
[TBL] [Abstract][Full Text] [Related]
7. Leukocytes from obese individuals exhibit an impaired SPM signature.
López-Vicario C; Titos E; Walker ME; Alcaraz-Quiles J; Casulleras M; Durán-Güell M; Flores-Costa R; Pérez-Romero N; Forné M; Dalli J; Clària J
FASEB J; 2019 Jun; 33(6):7072-7083. PubMed ID: 30840838
[TBL] [Abstract][Full Text] [Related]
8. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
9. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.
Fredman G; Ozcan L; Spolitu S; Hellmann J; Spite M; Backs J; Tabas I
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14530-5. PubMed ID: 25246560
[TBL] [Abstract][Full Text] [Related]
10. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
[TBL] [Abstract][Full Text] [Related]
11. Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment.
Kain V; Halade GV
J Cell Physiol; 2019 Apr; 234(4):3910-3920. PubMed ID: 30191990
[TBL] [Abstract][Full Text] [Related]
12. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D1 blocks H
Chattopadhyay R; Mani AM; Singh NK; Rao GN
Free Radic Biol Med; 2018 Mar; 117():119-131. PubMed ID: 29408202
[TBL] [Abstract][Full Text] [Related]
15. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure.
Tourki B; Kain V; Pullen AB; Norris PC; Patel N; Arora P; Leroy X; Serhan CN; Halade GV
Mol Metab; 2020 Jan; 31():138-149. PubMed ID: 31918915
[TBL] [Abstract][Full Text] [Related]
16. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
Mas E; Croft KD; Zahra P; Barden A; Mori TA
Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
[TBL] [Abstract][Full Text] [Related]
17. ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation.
Nunes VS; Abrahão O; Rogério AP; Serhan CN
J Phys Chem B; 2023 Jul; 127(29):6479-6486. PubMed ID: 37428488
[TBL] [Abstract][Full Text] [Related]
18. Identification of proresolving and inflammatory lipid mediators in human psoriasis.
Sorokin AV; Norris PC; English JT; Dey AK; Chaturvedi A; Baumer Y; Silverman J; Playford MP; Serhan CN; Mehta NN
J Clin Lipidol; 2018; 12(4):1047-1060. PubMed ID: 29730187
[TBL] [Abstract][Full Text] [Related]
19. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
[TBL] [Abstract][Full Text] [Related]
20. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.
Neuhofer A; Zeyda M; Mascher D; Itariu BK; Murano I; Leitner L; Hochbrugger EE; Fraisl P; Cinti S; Serhan CN; Stulnig TM
Diabetes; 2013 Jun; 62(6):1945-56. PubMed ID: 23349501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
